Anteris Technologies Global Corp.
NASDAQ:AVRMedical - Devices
Healthcare
$5.09 -0.16%
-$0.02 today
- Market cap
- $496.24M
- Beta
- 0.73
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$4.04
52W Low $2.85High $10.14
Volume 1.26M
Average 1.18M
Income Statement
Follow revenue through to earnings.
Revenue
$1.91M
FY 2025 · Annual
-29.2% YoYOperating Income
-$93.89M
FY 2025 · Annual
Net Income
-$94.14M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.83M | 3.2M | 2.73M | 2.7M | 1.91M |
| Cost of Revenue | 3.93M | 2.9M | 1.86M | 1.44M | 2.23M |
| Gross Profit | 1.91M | 298.38K | 876.8K | 1.27M | (317K) |
| Gross Margin | 32.7% | 9.3% | 32.1% | 46.8% | -16.6% |
| Research & Development | 9.99M | 17.59M | 31.02M | 51.45M | 69.12M |
| Selling, General & Admin | 9.14M | 15.21M | 17.05M | 0 | 24.46M |
| Operating Expenses | 18.77M | 31.41M | 49.02M | 79.64M | 93.58M |
| Depreciation & Amortization | 640.09K | 774.08K | 1.16M | 1.51M | 1.66M |
| EBITDA | (15.5M) | (29.14M) | (45.54M) | (74.38M) | (92.49M) |
| EBITDA Margin | -265.8% | -910.5% | -1665.1% | -2751.7% | -4834.9% |
| Operating Income | (16.86M) | (31.11M) | (48.14M) | (78.37M) | (93.89M) |
| Operating Margin | -289.2% | -972.1% | -1760.3% | -2899.4% | -4908.2% |
| Interest Income | 68.55K | 210.38K | 428.06K | 0 | 709K |
| Interest Expense | 1.03M | 648.71K | 67.09K | 82K | 73K |
| Other Income / Expenses | (310.48K) | 550.48K | 1.38M | 2.41M | (331K) |
| Income Before Tax | (17.17M) | (30.56M) | (46.76M) | (75.97M) | (94.23M) |
| Pre-Tax Margin | -294.5% | -954.9% | -1709.9% | -2810.5% | -4925.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (17.17M) | (30.56M) | (46.02M) | (76.29M) | (94.14M) |
| Net Margin | -294.5% | -954.9% | -1682.8% | -2822.5% | -4921.3% |
| EPS (Basic) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| EPS (Diluted) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| 35.94M | 35.94M | 35.94M | 20.25M | 23.58M | |
| 35.94M | 35.94M | 35.94M | 20.25M | 23.58M |
AVR Earnings Waterfall · TTM
NASDAQ:AVR · Revenue to Net Income
Key Ratios
EPS$-4.00
Gross Margin17.9%
Net Margin-5659.3%
P/E Ratio-1.2
P/S Ratio259.1
Analysis
$1.9M of revenue converted into -$95.3M of net income for the selected period. Gross margin is 17.9% and net margin is -5659.3%, showing how much revenue survives after costs and taxes. EPS is $-4.00, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 10-Q/A | 10-Q/A filing | Nov 9, 2026 | |
| 10-Q/A | 10-Q/A filing | Nov 9, 2026 | |
| ARS | ARS filing | Nov 9, 2026 |
How much revenue does AVR generate?
Anteris Technologies Global Corp. (AVR) reported $1.91M of revenue in fiscal 2025.
Is AVR profitable?
Anteris Technologies Global Corp. (AVR) reported -$94.14M of net income, with a net margin of -4921.3%.
Continue the stock analysis
Jump to another research area for this company.